RESUMEN
A gene therapy approach towards the modulation of neovascularization provides important advantages that could be crucial for the success of therapies that target blood vessels. These advantages include sustained local expression and the ability to supply multiple pro- or anti-angiogenic factors. There is potential near-term success in the application of this approach for the treatment of ischemic vascular diseases. Although there is convincing proof of concept in animal models that an anti-angiogenesis gene therapy approach can be used to treat cancer, this is a highly competitive field with small molecules, recombinant proteins and monoclonal antibodies already in clinical trials. The scientific rationale for the use of gene therapy is sound, but realization of its full potential for the treatment of a broad array of diseases will require several challenging technical hurdles to be overcome and safety concerns to be alleviated.
RESUMEN
Previous work from this laboratory suggests that animals decrease their intake of an amino acid imbalanced diet (IMB), due in part to a drop in the concentration of the dietary limiting amino (DLAA) in the anterior piriform cortex (APC). Administration of the DLAA, but not of a non-limiting amino acid into the APC, blocks the anorectic response to IMB. To our knowledge, the effects of DLAA injections on intake of a diet devoid of the DLAA (DEV), have not been examined in areas outside the APC. We hypothesized that the LH is a potential chemosensory area for DLAA. Our objectives were: (1) to determine whether injections of the DLAA threonine into the lateral hypothalamus (LH) alter intake of a threonine-devoid diet (DEV); and (2) to examine the dose-response effects of threonine injections into the LH on intake of threonine-corrected diet (COR). Administration of threonine into the LH stimulated DEV intake during the first 6 h at the 0.25 and 1-nmol doses by approximately 26 and 24%, respectively. Threonine (0.25, 2.5 nmol) did not alter COR intake at any time during the first 12 h. Our results suggest that: (1) the LH, along with the APC, likely acts as a chemosensory brain area for indispensable amino acids; and (2) both the APC and LH are part of a circuit that is involved in the short term anorectic response to amino acid imbalanced diets.
Asunto(s)
Aminoácidos/metabolismo , Dieta , Ingestión de Energía/efectos de los fármacos , Hipotálamo/fisiología , Treonina/farmacología , Animales , Anorexia , Hipotálamo/efectos de los fármacos , Masculino , Microinyecciones , Especificidad de Órganos , Ratas , Ratas Sprague-Dawley , Treonina/administración & dosificaciónRESUMEN
Both total subdiaphragmatic vagotomy (TVAGX) and serotonin(3) receptor blockade with tropisetron or ondansetron attenuate amino acid-imbalanced diet (Imb) anorexia. Total vagotomy is less effective than tropisetron in reducing Imb-induced anorexia and also blunts the tropisetron effect. With the use of electrocautery at the subdiaphragmatic level of the vagus, we severed the ventral and dorsal trunks as well as the hepatic, ventral gastric, dorsal gastric, celiac, and accessory celiac branches separately or in combination to determine which vagal branches or associated structures may be involved in these responses. Rats were prefed a low-protein diet. On the first experimental day, tropisetron or saline was given intraperitoneally 1 h before presentation of Imb. Cuts including the ventral branch, i.e., TVAGX, ventral vagotomy (above the hepatic branch), and hepatic + gastric vagotomies (but not hepatic branch cuts alone) caused the highest (P < 0.05) Imb intake on day 1 with or without tropisetron. The responses to tropisetron were not affected significantly. On days 2-8, groups having vagotomies that included the hepatic branch recovered faster than sham-treated animals. Because the hepatic and gastric branches together account for most of the vagal innervation to the proximal duodenum, this area may be important in the initial responses, whereas structures served by the hepatic branch alone apparently act in the later adaptation to Imb.
Asunto(s)
Aminoácidos/deficiencia , Aminoácidos/farmacología , Indoles/farmacología , Antagonistas de la Serotonina/farmacología , Vagotomía/métodos , Adaptación Fisiológica/fisiología , Animales , Anorexia/tratamiento farmacológico , Anorexia/fisiopatología , Anorexia/cirugía , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Diafragma , Dieta , Duodeno/inervación , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Hígado/inervación , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de Serotonina/metabolismo , Receptores de Serotonina 5-HT3 , Estómago/inervación , Tropisetrón , Nervio Vago/fisiología , Nervio Vago/cirugíaRESUMEN
Repeated subthreshold stimulation of limbic brain areas increases seizure susceptibility in experimental models of epilepsy. In addition, acute dietary indispensable amino acid (IAA) deficiency activates the anterior piriform cortex (APC), a seizure-prone limbic brain area in the rat. Based on these two findings, we hypothesized that activation of the APC by chronic exposure to IAA-deficient diets might increase seizure susceptibility. Several nonessential amino acid neurotransmitters are important in seizures, but deficiencies of nontransmitter IAAs have not been well studied in seizure models. In four trials, we made injections of pentylenetetrazole intraperitoneally or of bicuculline into the APC in histidine-, isoleucine-, or threonine-deficient rats and controls. Increased susceptibility to seizures in the deficient animals was observed as increased severity of the seizures, decreased threshold for the dose of the chemostimulant and time to seizure, or a combination thereof. Pair-fed controls showed that this effect was not due to an energy deficit. This novel but robust finding suggests that IAA deficiency may increase vulnerability to seizures by repeated activation of the APC.
Asunto(s)
Aminoácidos/deficiencia , Convulsiones/inducido químicamente , Animales , Bicuculina/farmacología , Umbral Diferencial , Susceptibilidad a Enfermedades , Esquema de Medicación , Histidina/deficiencia , Inyecciones , Inyecciones Intraperitoneales , Isoleucina/deficiencia , Sistema Límbico/efectos de los fármacos , Sistema Límbico/fisiología , Masculino , Vías Olfatorias/efectos de los fármacos , Vías Olfatorias/fisiología , Pentilenotetrazol/administración & dosificación , Pentilenotetrazol/farmacología , Ratas , Ratas Sprague-Dawley , Treonina/deficienciaRESUMEN
Rats offered an amino acid-imbalanced diet (IMB) respond to the ensuing amino acid deficiency rapidly with a decrease in food intake of at least 50%. Pretreatment with tropisetron (TROP), an antagonist at serotonin3 (5-HT3) and 5-HT4 receptors, increases intake of IMB to approximately 85% of control. Vagotomy has two effects: it increases intake of an IMB to about 65%, and also blocks the increased response to tropisetron. This indicates that the greater IMB intake after tropisetron, approximately 20% more than in vagotomized rats, is dependent on an intact vagus. Rats were either 1) vagotomized or sham-operated, or 2) given tropisetron or saline injections. We then examined free-feeding meal patterns in rats fed an IMB to determine whether the microstructure of the feeding behavior differed, either between treatments, or by comparison with the meal patterns in rats fed the control diet. Vagotomy did not alter meal patterns in rats consuming the basal control diet. During the first 6 h after introduction of the IMB, the control rats showed significantly longer intermeal intervals (over twice the length of intervals recorded in those fed the basal diet), with corresponding effects on meal numbers, which were restored to basal values in tropisetron and vagotomized rats. Meal size was increased after vagotomy also. After 6 h, in intact tropisetron-treated rats only, a fourfold faster rate of eating throughout the late dark period accounted for the significantly greater intake of the IMB than in controls. The results demonstrated differential effects of the two treatments on the anorectic responses to amino acid deficiency.